Provision of cellular blood components to CMV-seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres.
Suzy MortonA PeniketR MalladiM F MurphyPublished in: Transfusion medicine (Oxford, England) (2017)
The survey demonstrated a surprisingly high rate (22.7%) of centres continuing to provide blood components from CMV-seronegative donors despite SaBTO guidance.